Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Lecomte is active.

Publication


Featured researches published by P. Lecomte.


Diabetes & Metabolism | 2011

Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys)

Carole Pornet; Isabelle Bourdel-Marchasson; P. Lecomte; Eveline Eschwège; I. Romon; S. Fosse; F. Assogba; Candice Roudier

AIM This study aimed to characterize the sociodemographic data, health status, quality of care and 6-year trends in elderly people with type 2 diabetes. METHODS This study used two French cross-sectional representative surveys of adults of all ages with all types of diabetes (Entred 2001 and 2007), which combined medical claims, and patient and medical provider questionnaires. The 2007 data in patients with type 2 diabetes aged 65 years or over (n=1766) were described and compared with the 2001 data (n=1801). RESULTS Since 2001, obesity has increased (35% in 2007; +7 points since 2001) while written nutritional advice was less often provided (59%; -6 points). Mean HbA(1c) (7.1%; -0.2%), blood pressure (135/76 mmHg; -4/-3 mmHg) and LDL cholesterol (1.04 g/L; -0.21 g/L) declined, while the use of medication increased: at least two OHAs, 34% (+4 points); OHA(s) and insulin combined, 10% (+4 points); antihypertensive treatment, 83% (+4 points); and statins 48% (+26 points). Severe hypoglycaemia remained frequent (10% had an event at least once a year). The overall prevalence of complications increased. Renal complications were not monitored carefully enough (missing value for albuminuria: 42%; -4.5 points), and 46% of those with a glomerular filtration rate less than 60 mL/min/1.73 m² were taking metformin. CONCLUSION Elderly people with type 2 diabetes are receiving better quality of care and have better control of cardiovascular risk factors than before. However, improvement is still required, in particular by performing better screening for complications. In this patient population, it is important to carefully monitor the risks for hypoglycaemia, hypotension, malnutrition and contraindications related to renal function.


Journal of Nutrition Health & Aging | 2009

Key priorities in managing glucose control in older people with diabetes

Isabelle Bourdel-Marchasson; J. Doucet; B. Bauduceau; Gilles Berrut; J.-F. Blickle; P. Brocker; T. Constans; E. Kaloustian; V. Lassmann-Vague; P. Lecomte; Dominique Simon; Daniel Tessier; C. Verny; Ulrich M. Vischer

Older people with diabetes represent a major and increasing proportion of our elderly population and their care requires better organisation. Targets for risk factor control and pathways of care must be adjusted to the subjects general health status. It is thus advisable to screen for frailty. We have carried out a detailed literature review of the studies published on diabetes in older people since 1990. Studies were considered if they included groups or subgroups of diabetic patients > 65 years old. This review discusses the elaboration of general targets for care, the approach to risk factor control, the screening and the specific prevention or management of complications, the integration of geriatric concepts in diabetes care and the specificity of education with respect to frailty status.


Diabetes & Metabolism | 2008

Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: The Entred study 2001

P. Lecomte; I. Romon; S. Fosse; Dominique Simon

OBJECTIVE To describe the practice of self-monitoring blood glucose (SMBG) testing and to determine factors linked to SMBG in people with diabetes living in France. METHODS The 2001 Entred study, a French national survey of people being treated for diabetes, is based on a representative sample of 10,000 adults who claimed reimbursement for oral hypoglycaemic agents and/or insulin in October to December 2001 and who were randomly extracted from the database of the major National Health Insurance System. A questionnaire was mailed to all these people and was returned by 36% of them, who were then classified into three groups: type 1 diabetes (T1D, N=235); type 2 diabetes treated with insulin (iT2D, N=635); and type 2 diabetes treated with oral hypoglycaemic agents (oT2D, N=2689). Factors associated with SMBG were analyzed using logistic regression models with a step-by-step forward approach. RESULTS HbA(1c) was greater than or equal to 8% in 42% of people with T1D, 48% of those with iT2D and 21% of those with oTD2. Almost all of those treated with insulin performed SMBG. The frequency of self-monitoring was higher in T1D than in iT2D. In T1D, 58% of people reported they took at least three tests a day, as recommended in guidelines, which was more frequent in those who knew what HbA(1c) meant and in women. In iT2D, 74% reported that they took at least two tests a day, as recommended, and it was more frequent in those who knew what HbA(1c) meant, who reported at least one severe hypoglycaemic episode in 2001 and who received dietary advice from their practitioner. In oT2D, 38% reported using SMBG (six tests a week on average), even though no official recommendation had been provided for these patients. SMBG was also more frequent in patients being treated with multiple oral hypoglycaemic agents, in those who benefited from a waiver of co-payment due to a chronic disease and in those, who had visited a diabetes specialist in 2001, reported they knew what HbA(1c) meant, received dietary advice and reported at least one severe hypoglycaemic episode in 2001 and/or a history of diabetes complications. CONCLUSION In France, as per the official recommendations, almost all people on insulin treatment use a SMBG device while, overall, their glucose control remains poor. More than one-third of those with oT2D regularly perform SMBG. In only 3% of people, the regular use of SMBG does not appear to be related to any special needs or events (such as insulin treatment, occurrence of severe hypoglycaemia or chronic complications).


Diabetes & Metabolism | 2007

Non pharmacological treatments in elderly diabetics

T. Constans; P. Lecomte

Among the therapeutic resources available for the elderly diabetic, diet and exercise are often neglected because patients are reluctant to make changes and significant amount of time of healthcare providers and physicians is required for patient education. Diet and exercise work in synergy to lower the biological parameters of diabetes control. Diet in the elderly diabetic patient is based essentially on the nutritional recommendations for the elderly subject, diabetic or non diabetic. Recent studies on exercise demonstrate the value of resistance training in increasing muscle mass, preferably over endurance training. The benefits obtained also involve autonomy and quality of life. Taking up exercise is not devoid of disadvantages because of the frequent co-morbidity at this age.


Diabetes & Metabolism | 2013

Underdiagnosis of obstructive sleep apnoea syndrome in patients with type 2 diabetes in France: ENTRED 2007

P. Lecomte; L. Criniere; C. Druet; C. Fuhrman


Diabetes & Metabolism | 2015

Physical activity at home, at leisure, during transportation and at work in French adults with type 2 diabetes: the ENTRED physical activity study.

L. Cloix; A. Caille; Catherine Helmer; Isabelle Bourdel-Marchasson; C. Fournier; P. Lecomte; Jean-Michel Oppert; D. Jacobi


Diabetes & Metabolism | 2012

O62 Hospitalisations des personnes diabétiques en France - Entred 2007–2010

F. Assogba; P. Lecomte; F. Penfornis; B. Detournay; Isabelle Bourdel-Marchasson; C. Druet; S. Fosse


Diabetes & Metabolism | 2012

P6 Activité physique des personnes traitées pour diabète de type 2 vivant en France : Répartition par domaines et déterminants (ENTRED 2007–2010)

L. Cloix; A. Caille; Catherine Helmer; C. Fournier; Jean-Michel Oppert; P. Lecomte; D. Jacobi


/data/revues/12623636/v35i3/S1262363609000500/ | 2009

A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly

Ulrich M. Vischer; B. Bauduceau; Isabelle Bourdel-Marchasson; J.-F. Blickle; T. Constans; E. Kaloustian; V. Lassman-Vague; P. Lecomte; Dominique Simon; Daniel Tessier; C. Verny; J. Doucet

Collaboration


Dive into the P. Lecomte's collaboration.

Top Co-Authors

Avatar

Isabelle Bourdel-Marchasson

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

S. Fosse

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

T. Constans

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

C. Druet

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Jacobi

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

F. Assogba

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

I. Romon

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.-F. Blickle

University of Strasbourg

View shared research outputs
Researchain Logo
Decentralizing Knowledge